Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) - Total Assets
Latest total assets as of September 2025: CN¥9.71 Billion CNY
Based on the latest financial reports, Guangzhou Kingmed Diagnostics Group Co Ltd (603882) holds total assets worth CN¥9.71 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Guangzhou Kingmed Diagnostics Group Co Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Guangzhou Kingmed Diagnostics Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Guangzhou Kingmed Diagnostics Group Co Ltd's total assets of CN¥9.71 Billion consist of 70.4% current assets and 29.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 23.4% |
| Accounts Receivable | CN¥4.51 Billion | 43.4% |
| Inventory | CN¥198.32 Million | 1.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥170.89 Million | 1.6% |
| Goodwill | CN¥52.21 Million | 0.5% |
Asset Composition Trend (2012–2024)
This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangzhou Kingmed Diagnostics Group Co Ltd's current assets represent 70.4% of total assets in 2024, a decrease from 75.1% in 2012.
- Cash Position: Cash and equivalents constituted 23.4% of total assets in 2024, down from 28.6% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 43.4% of total assets.
Guangzhou Kingmed Diagnostics Group Co Ltd Competitors by Total Assets
Key competitors of Guangzhou Kingmed Diagnostics Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩42.32 Billion |
|
Bionet
TWO:1784
|
Taiwan | NT$3.10 Billion |
Guangzhou Kingmed Diagnostics Group Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Guangzhou Kingmed Diagnostics Group Co Ltd generates 0.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Guangzhou Kingmed Diagnostics Group Co Ltd is currently not profitable relative to its asset base.
Guangzhou Kingmed Diagnostics Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.14 | 3.28 | 2.06 |
| Quick Ratio | 3.05 | 3.18 | 1.96 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.59 Billion | CN¥ 5.28 Billion | CN¥ 2.45 Billion |
Guangzhou Kingmed Diagnostics Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangzhou Kingmed Diagnostics Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.12 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -11.7% |
| Total Assets | CN¥10.39 Billion |
| Market Capitalization | $1.10 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Guangzhou Kingmed Diagnostics Group Co Ltd's assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guangzhou Kingmed Diagnostics Group Co Ltd's assets decreased by 11.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2024)
The table below shows the annual total assets of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥10.39 Billion | -11.69% |
| 2023-12-31 | CN¥11.77 Billion | -15.28% |
| 2022-12-31 | CN¥13.89 Billion | +29.21% |
| 2021-12-31 | CN¥10.75 Billion | +61.93% |
| 2020-12-31 | CN¥6.64 Billion | +51.05% |
| 2019-12-31 | CN¥4.40 Billion | +11.07% |
| 2018-12-31 | CN¥3.96 Billion | +19.16% |
| 2017-12-31 | CN¥3.32 Billion | +24.50% |
| 2016-12-31 | CN¥2.67 Billion | +33.22% |
| 2015-12-31 | CN¥2.00 Billion | +43.83% |
| 2014-12-31 | CN¥1.39 Billion | +61.77% |
| 2013-12-31 | CN¥860.64 Million | +36.84% |
| 2012-12-31 | CN¥628.95 Million | -- |